Natixis Advisors, L.P. Trans Medics Group, Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 62,687 shares of TMDX stock, worth $4.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,687
Previous 78,073
19.71%
Holding current value
$4.03 Million
Previous $12.3 Million
68.11%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding TMDX
# of Institutions
347Shares Held
30.6MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$234 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$170 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$87.6 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$64.4 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$63.9 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.05B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...